Wordt geladen...
Targeting PD-1/PD-L1 in lung cancer: current perspectives
Increased understanding of tumor immunology has led to the development of effective immunotherapy treatments. One of the most important advances in this field has been due to pharmacological design of antibodies against immune checkpoint inhibitors. Anti-PD-1/PD-L1 antibodies are currently in advanc...
Bewaard in:
| Gepubliceerd in: | Lung Cancer (Auckl) |
|---|---|
| Hoofdauteurs: | , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Dove Medical Press
2015
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5217517/ https://ncbi.nlm.nih.gov/pubmed/28210151 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/LCTT.S55176 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|